Safety and Tolerability of Subcutaneous Methotrexate in Routine Clinical Practice.

Ka Hou Christien Li Kenneth F Baker Tania JonesElizabeth CoulsonAndrew RobertsFraser Birrell

Published in: Arthritis care & research (2021)

Subcutaneous MTX is safe in routine clinical practice. This is the largest study yet reported on SC MTX and provides observational data that SC MTX is continued longer and better tolerated in patients compared to other therapy groups, especially oral MTX.

Keyphrases

high dose
clinical practice
end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
peritoneal dialysis
open label
electronic health record
machine learning
smoking cessation